Skip to main content
Caplight Logo









Boomerang Medical

Boomerang Medical

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://www.boomerangmedical.com/

Last Round

Series B

Sep 4, 2025

Est. Valuation

$75M

Total Funding Raised

$38M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Boomerang Medical is a bioelectronic medicine company developing neuromodulation technology to treat autoimmune diseases, with an initial focus on inflammatory bowel disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

neuromodulationbioelectronic medicineimplantable deviceinflammatory bowel diseaseIBDulcerative colitismedtechnerve stimulationclinical trialsFDA breakthrough deviceautoimmune disease treatmentnon-pharmaceutical therapybioelectronicsgastroenterologymedical device startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Boomerang Medical Comparables

Compare Boomerang Medical with similar companies based on industry and business-model similarity.

Boomerang Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SetPoint Medical
77%
GSK plc
69%
LivaNova
62%

Boomerang Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 4, 2025
Series ANov 1, 2022
SeedOct 18, 2021

Boomerang Medical Investors

Notable investors and investment history

Boomerang Medical investors
InvestorRounds
Arboretum VenturesSeries A, Series B, Seed
Hatteras Venture PartnersSeries A, Series B
Fogarty InnovationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 22, 2026

    Grew 20% QoQ, from 15 to 18 employees.

  • Sep 4, 2025

    $20M round completed.

Boomerang Medical Filings

Explore SEC and related filing metadata, where available.

Boomerang Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Boomerang Medical's valuation, stock price, and market status.

Is Boomerang Medical a public or private company?

Boomerang Medical is a private company.

What is the current stock price of Boomerang Medical?

Boomerang Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Boomerang Medical worth (valuation)?

Valuation information for Boomerang Medical is not publicly available.

Can I buy Boomerang Medical stock?

Boomerang Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Boomerang Medical's last funding round?

Boomerang Medical's most recent funding round was Series B on September 4, 2025.

Who are the main investors in Boomerang Medical?

Key investors in Boomerang Medical include Arboretum Ventures, Hatteras Venture Partners.

Will Boomerang Medical IPO soon?

No public IPO plans have been announced for Boomerang Medical.

How can I track Boomerang Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Boomerang Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMountain View, California
Employee Range12
Year Founded2021
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?